Skip to content

Interpersonal Psychotherapy for Adolescent Girls

Prevention of Depression in Maltreated and Nonmaltreated Adolescents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01534377
Acronym
IPT
Enrollment
328
Registered
2012-02-16
Start date
2011-07-31
Completion date
2018-06-30
Last updated
2018-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Depression, Adolescents

Brief summary

This study will evaluate the efficacy of Interpersonal Psychotherapy for Adolescents (IPT-A) for the treatment of depression and prevention of depression in maltreated and nonmaltreated girls between the ages of 13-15 years old.

Detailed description

Child maltreatment poses a serious public health problem and heightens the risk of psychopathology across the life course. Adolescence also represents a peak time for the emergence of depressive disorders particularly in girls. Effective interventions to prevent and treat depression in low income adolescent girls with or without histories of maltreatment are needed. Three groups will be recruited: Maltreated Depressive Symptoms (MDS), Nonmaltreated Depressive Symptoms (NDS), and a Nonmaltreated Nonsymptomatic Comparison (NNC), comparable in SES, race/ethnicity, and household composition. The MDS and NDS groups will be randomized into IPT-A or Enhanced Care (EC). Adolescent girls in these groups will receive 13 sessions of therapy. Girls in the NNC group will only complete research visits. Research assessments will be conducted at T1 (baseline/prior to intervention), T2 (6-weeks mid-intervention), T3 (end of intervention), T4 (1-year post) and T5 (18 months post). Girls and their mothers will participate in these research sessions. A multi-level-of-analysis approach, integrating genotyping, hormone assays, cognitive testing, adolescent- and maternal-report, mother-teen observation, and DHS and school records will be utilized to assess the effectiveness of the interventions.

Interventions

Adolescents will receive IPT-A a manualized intervention for depression and prevention of depression that emphasizes current interpersonal relationships, focusing on their immediate social context.

BEHAVIORALEnhanced Care

Adolescents will receive enhanced care which is consistent with care typically provided in community settings to treat and prevent depression.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of Rochester
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
13 Years to 15 Years
Healthy volunteers
Yes

Inclusion criteria

* girls * ages 13-15 years old * low SES status * live in Rochester or surrounding counties * girls in the maltreated depressive symptom group will have CPS-documented child maltreatment * girls in the nonmaltreated depressive symptom group will not have CPS- documented child maltreatment * girls in the nonmaltreated nonsymptomatic comparison group will have no current or past mental illness and no documented child maltreatment

Exclusion criteria

* taking antidepressants or prescription medications for anxiety * already receiving mental health treatment * actively suicidal * diagnosed with a severe mental disorder * abusing drugs or alcohol * evidence of compromised cognitive ability * evidence of a pervasive developmental disorder * evidence of a major physical or neurological disorder * non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
Change in adolescent depressive symptoms from baseline to post-interventionBaseline and 12 weeks, follow up at 1 year & again at 18 months post interventionTo evaluate the efficacy of Interpersonal Psychotherapy for Adolescents (IPT-A) for decreasing depressive symptoms and preventing depression in low-income ethnically and culturally diverse adolescent girls with and without histories of child maltreatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026